Eliem Therapeutics Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Eliem Therapeutics.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for ELYM.

Recommendation Trends

Rating	Oct '22	Nov '22	Dec '22	Jan '23	Feb '23
Strong Buy	1	1	1	1	0
Buy	1	1	1	1	1
Hold	1	1	1	1	2
Sell	0	0	0	0	0
Strong Sell	0	0	0	0	0
Total	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $6	Hold	Reiterates	$6	+55.04%	Mar 8, 2023
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Feb 10, 2023
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $6	Strong Buy	Initiates	$6	+55.04%	Oct 28, 2022
Marc Goodman SVB Leerink	SVB Leerink	Buy Maintains $9 → $4	Buy	Maintains	$9 → $4	+3.36%	Aug 16, 2022
Marc Goodman SVB Leerink	SVB Leerink	Buy Maintains $13 → $9	Buy	Maintains	$13 → $9	+132.56%	Jul 11, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-0.53

from -1.30

EPS Next Year

-0.63

from -0.53

Year	2019	2020	2021	2022	2023	2024	2025
Revenue	-	-	-	-	-	-	-
Revenue Growth	-	-	-	-	-	-	-
EPS	-4.45	-10.49	-4.24	-1.72	-1.30	-0.53	-0.63
EPS Growth	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2024	2025
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2024	2025
High	-0.55	-0.65
Avg	-0.53	-0.63
Low	-0.51	-0.61

EPS Growth

EPS Growth	2024	2025
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.